Literature DB >> 7828302

Do patients with primary pulmonary hypertension develop extensive central thrombi?

K M Moser1, P F Fedullo, W E Finkbeiner, J Golden.   

Abstract

BACKGROUND: Distinguishing chronic major vessel thromboembolic pulmonary hypertension from primary pulmonary hypertension is critical because the treatment options differ markedly. Surgical thromboendarterectomy is potentially curative in the former condition, whereas oxygen, vasodilators, perhaps anticoagulation, and lung transplantation are the options for the latter. The development of large thrombi in the main, right, or left pulmonary arteries has not been previously described in patients with primary pulmonary hypertension. METHODS AND
RESULTS: Three pulmonary hypertensive patients with massive thrombi in the central pulmonary arteries are described. The data indicate that the large central thrombi in these three patients were not hemodynamically significant. In none did perfusion lung scans demonstrate segmental or larger defects.
CONCLUSIONS: Large central thrombi can develop in patients with primary pulmonary hypertension. Perfusion lung scans that do not demonstrate segmental or larger defects should alert physicians to this possibility. Chest computed tomography and other studies identifying such thrombi are not adequate in distinguishing such a development from operable chronic major vessel thromboembolic hypertension. Careful review of lobar and segmental artery findings and the pulmonary angiogram, angioscopy, and cardiac catheterization data demonstrating the hemodynamic significance (or lack thereof) of these thrombi are essential in making this important distinction. Furthermore, these observations may constitute an additional indication for anticoagulant therapy in primary pulmonary hypertension.

Entities:  

Mesh:

Year:  1995        PMID: 7828302     DOI: 10.1161/01.cir.91.3.741

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Pulmonary arterial hypertension: new ideas and perspectives.

Authors:  N Galiè; A Torbicki
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

2.  Diagnostic value of transoesophageal echocardiography in suspected haemodynamically significant pulmonary embolism.

Authors:  P Pruszczyk; A Torbicki; A Kuch-Wocial; M Szulc; R Pacho
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

3.  Comparison of bronchopulmonary collaterals and collateral blood flow in patients with chronic thromboembolic and primary pulmonary hypertension.

Authors:  J Endrys; N Hayat; G Cherian
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

4.  Thromboembolism in primary pulmonary hypertension.

Authors:  A Bishop; P Oldershaw
Journal:  BMJ       Date:  1996-12-07

5.  Registry to evaluate early and long-term disease management in PAH (REVEAL).

Authors:  Balaji Pakshirajan; Ajit S Mullasari
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 6.  Approach to pulmonary hypertension.

Authors:  G L Yung; L J Rubin
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

7.  Pulmonary arterial thrombosis in a patient with an atrial septal defect and eisenmenger syndrome.

Authors:  Ching-Wei Lee; Shao-Sung Huang; Po-Hsun Huang
Journal:  Korean Circ J       Date:  2012-11-28       Impact factor: 3.243

8.  Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension.

Authors:  Jay Suntharalingam; Rajiv D Machado; Linda D Sharples; Mark R Toshner; Karen K Sheares; Rodney J Hughes; David P Jenkins; Richard C Trembath; Nicholas W Morrell; Joanna Pepke-Zaba
Journal:  Thorax       Date:  2007-02-07       Impact factor: 9.139

9.  Pulmonary hypertension and pulmonary artery dissection.

Authors:  Ricardo de Amorim Corrêa; Luciana Cristina dos Santos Silva; Cláudia Juliana Rezende; Rodrigo Castro Bernardes; Tarciane Aline Prata; Henrique Lima Silva
Journal:  J Bras Pneumol       Date:  2013 Mar-Apr       Impact factor: 2.624

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.